Startup | November 18, 2021
Illumina and Sequoia Capital China selects startups for Genomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Nelarabine is in a class of medications called antimetabolites
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The Summit will also witness participation of Union Minister of Health & Family Welfare and Chemicals & Fertilizers Dr. Mansukh Mandaviya
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
